Research Article
A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion
| | | PDAC group | Benign lesions |
| | Mean age (±SD) | 62 ± 9 | 54 ± 13 |
| | Gender (female (%)/male (%)) | 89 (38,03%)/145 (61,97%) | 30 (32,61%)/62 (67,39%) |
| | Resectable (%)/unresectable (%) | 66 (28,21%)/168 (71,79%) | 53 (57,6%)/39 (42,4%) |
| Stage I/II
| 66
| | | Stage III | 127 | | | Stage IV | 41 | |
|
|
